Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.100
-0.075 (-6.38%)
Feb 10, 2026, 5:22 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 33.44 million as of February 10, 2026. Its market cap has decreased by -60.84% in one year.
Market Cap
33.44M
Enterprise Value
25.52M
Revenue
36.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.10
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 33.44M, a decrease of -86.41%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 35.72M | 2.17% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.91B |
| Orexo AB | 1.03B |
| Cinclus Pharma Holding AB | 777.18M |
| Dicot Pharma AB | 650.02M |
| Nanexa AB | 601.56M |
| Enzymatica AB | 442.99M |
| Moberg Pharma AB | 440.63M |
| Klaria Pharma Holding AB (publ.) | 227.77M |